BeStock  
Stocks › AXSM

Axsome Therapeutics AXSM

US equityMarket cap rank #1751
$129.36 −$6.32 (-4.66%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $129.36 0.00%
Open$133.92
Prev close$135.68
Day range$128.23 – $135.09
Volume811.8K
Market cap$6.80B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$259.69M+51.9% YoY
Operating profit-$13.45M+59.2% YoY
Net profit-$12.88M+72.7% YoY
Diluted EPS-$0.25+73.4% YoY
Free cash flow-$9.67M-1,078.3% YoY
Operating cash flow-$9.47M

Revenue, last 8 quarters

$118.8MDec '24$121.5MMar '25$150.0MJun '25$171.0MSep '25$196.0MDec '25$191.2MMar '26$218.4MJun '26$259.7MSep '26

Net profit, last 8 quarters

$-74.9MDec '24$-59.4MMar '25$-48.0MJun '25$-47.2MSep '25$-28.6MDec '25$-64.5MMar '26$-51.3MJun '26$-12.9MSep '26

Diluted EPS by quarter

-1.54Dec '24-1.22Mar '25-0.97Jun '25-0.94Sep '25-0.56Dec '25-1.26Mar '26-0.99Jun '26-0.25Sep '26

Free cash flow by quarter

$-26.2MDec '24$-43.7MMar '25$-32.4MJun '25$988.0KSep '25$-18.7MDec '25$-20.8MMar '26$-33.4MJun '26$-9.7MSep '26

Annual revenue

$0.0FY20$0.0FY21$50.0MFY22$270.6MFY23$385.7MFY24$638.5MFY25

Profitability & balance sheet

Gross margin93.2%
Operating margin-18.9%
Net margin-18.2%
Return on equity-175.6%
Return on assets-21.0%
Return on invested capital-49.5%
Current ratio1.42
Liabilities / assets87.2%
Cash & investments$313.86M
Total debt$218.01M
Net cash (debt)$95.85M

Where the revenue comes from

Quarter 2026/Q3

By business line

  • AUVELITY$207.61M 79.9%
  • Sunosi$38.45M 14.8%
  • SUNOSI milestone revenue$8.51M 3.3%
  • Symbravo$3.89M 1.5%
  • SUNOSI royalty revenue$1.23M 0.5%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $259.69M $218.38M $191.20M $638.50M $196.00M
Total Operating Revenue $259.69M $218.38M $191.20M $638.50M $196.00M
Cost of Revenue $17.80M $13.56M $14.73M $47.48M $12.33M
Gross Profit $241.89M $204.81M $176.48M $591.02M $183.67M
Operating Expense $255.34M $255.95M $239.25M $760.25M $219.70M
Selling and Admin Expenses $203.11M $208.14M $185.00M $570.60M $169.30M
Research & Development $50.62M $46.23M $52.68M $183.28M $48.79M
Depreciation & Amortization & Depletion $1.61M $1.59M $1.57M $6.38M $1.61M
-Depreciation & Amortization $1.61M $1.59M $1.57M $6.38M $1.61M
Operating Profit -$13.45M -$51.14M -$62.77M -$169.24M -$36.03M
Net Non-Operating Interest Income (Expense) -$1.72M -$1.54M -$1.19M -$6.56M -$1.17M
Non-Operating Interest Expense $1.72M $1.54M $1.19M $6.56M $1.17M
Other Income (Expense) $2.38M $1.50M -$590,000.00 -$7.91M $9.07M
Special Income (Charges) $2.38M $1.50M -$590,000.00 -$7.91M $9.07M
-Less:Restructuring and Mergern & Acquisition -$2.38M -$1.50M $590,000.00 -$2.47M -$9.07M
Pretax Profit -$12.79M -$51.19M -$64.54M -$183.70M -$28.13M
Tax $88,000.00 $128,000.00 $0.00 -$530,000.00 $430,000.00
Net Profit -$12.88M -$51.31M -$64.54M -$183.17M -$28.56M
Profit from Continuing Operations -$12.88M -$51.31M -$64.54M -$183.17M -$28.56M
Net Income to Parent Company -$12.88M -$51.31M -$64.54M -$183.17M -$28.56M
Net Income to Common Stockholders -$12.88M -$51.31M -$64.54M -$183.17M -$28.56M
Basic EPS -$0.25 -$0.99 -$1.26 -$3.68 -$0.56
Diluted EPS -$0.25 -$0.99 -$1.26 -$3.68 -$0.56
-Less:Other Special Charges – – – $10.39M $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $826.77M $761.45M $713.61M $689.81M $689.81M
Total Current Assets $724.64M $656.57M $611.21M $588.99M $588.99M
Cash and Cash Equivalents & Short-Term Investments $313.86M $319.85M $305.11M $322.93M $322.93M
-Cash and Cash Equivalents $313.86M $319.85M $305.11M $322.93M $322.93M
Receivables $343.11M $277.46M $251.06M $224.46M $224.46M
-Accounts Receivable $343.11M $277.46M $251.06M $224.46M $224.46M
Inventory $42.58M $37.88M $31.52M $27.94M $27.94M
Other Current Assets $25.08M $21.38M $23.52M $13.65M $13.65M
Total Non-Current Assets $102.14M $104.88M $102.40M $100.82M $100.82M
Net PPE $19.23M $20.03M $20.58M $21.42M $21.42M
-Gross PPE $19.23M $20.03M $20.58M $21.42M $21.42M
Goodwill and Other Intangible Assets $47.79M $49.40M $50.99M $52.56M $52.56M
-Goodwill $12.04M $12.04M $12.04M $12.04M $12.04M
-Other Intangible Assets $35.75M $37.36M $38.95M $40.52M $40.52M
Other Non-Current Assets $35.12M $35.45M $30.83M $26.84M $26.84M
Total Liabilities $721.34M $678.14M $659.02M $601.51M $601.51M
Total Current Liabilities $509.72M $460.45M $439.21M $378.84M $378.84M
Payables $96.08M $78.97M $106.80M $65.64M $65.64M
-Accounts Payable $96.08M $78.97M $106.70M $65.54M $65.54M
-Total Tax Payable $0.00 $0.00 $99,000.00 $101,000.00 $101,000.00
Current Accrued Expenses $284.34M $261.21M $220.42M $193.27M $193.27M
Short-Term Debt and Capital Lease Obligation $76.22M $76.13M $73.82M $72.98M $72.98M
-Current Debt $70.00M $70.00M $70.00M $70.00M $70.00M
-Current Capital Lease Obligation $6.22M $6.13M $3.82M $2.98M $2.98M
Other Current Liabilities $11.23M $11.20M $11.15M $10.01M $10.01M
Total Non-Current Liabilities $211.62M $217.70M $219.81M $222.67M $222.67M
Long Term Debt and Capital Lease Obligation $148.01M $148.56M $146.08M $145.13M $145.13M
-Long Term Debt $118.07M $117.96M $117.85M $117.75M $117.75M
-Long Term Capital Lease Obligation $29.94M $30.60M $28.23M $27.39M $27.39M
Other Non-Current Liabilities $63.61M $69.14M $73.73M $77.54M $77.54M
Total Equity $105.43M $83.30M $54.59M $88.30M $88.30M
Stockholders' Equity $105.43M $83.30M $54.59M $88.30M $88.30M
Capital Stock $5,000.00 $5,000.00 $5,000.00 $5,000.00 $5,000.00
-Common Stock $5,000.00 $5,000.00 $5,000.00 $5,000.00 $5,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.54B $1.51B $1.43B $1.39B $1.39B
Retained Earnings -$1.43B -$1.42B -$1.37B -$1.31B -$1.31B

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$9.47M -$32.95M -$20.70M -$93.41M -$18.65M
Net cash flow from continuing operations -$9.47M -$32.95M -$20.70M -$93.41M -$18.65M
Net Income from Continuing Operations -$12.88M -$51.31M -$64.54M -$183.17M -$28.56M
Depreciation & Depletion & Amortization $3.06M $2.89M $2.37M $9.06M $2.27M
Other Non-Cash Items -$2.15M -$1.26M $985,000.00 -$909,000.00 -$8.27M
Change in Working Capital -$23.86M -$10.41M $17.05M -$22.52M -$6.83M
-Change in Receivables -$65.66M -$26.40M -$26.60M -$82.46M -$27.96M
-Change in Inventory -$3.66M -$5.04M -$4.87M -$15.67M -$3.49M
-Change in Prepaid Assets -$3.71M $2.15M -$9.87M -$1.67M $6.14M
-Change in Payables and Accrued Expense $49.16M $18.88M $58.39M $77.28M $18.48M
Net cash flow from investing -$197,000.00 -$450,000.00 -$121,000.00 -$480,000.00 -$71,000.00
Net Cash Flow from Continuing Investing Activities -$197,000.00 -$450,000.00 -$121,000.00 -$480,000.00 -$71,000.00
Net PPE Purchase and Sale -$197,000.00 -$450,000.00 -$121,000.00 -$480,000.00 -$71,000.00
Financing Cash Flow $3.68M $48.15M $2.99M $101.47M $16.39M
Net Cash Flow from Continuing Financing Activities $3.68M $48.15M $2.99M $101.47M $16.39M
Net Issuance Payments Of Debt -$1.42M -$1.21M -$672,000.00 -$4.11M -$541,000.00
Net Common Stock Issuance $0.00 $13.47M $6.34M $67.90M $5.68M
Proceeds from Stock Option Exercised $10.06M $41.97M $9.98M $59.56M $15.34M
Net Other Financing Charges -$4.96M -$6.09M -$12.66M -$21.89M -$4.09M
Ending Cash Balance $313.86M $319.85M $305.11M $322.93M $322.93M
Net Change in Cash -$5.99M $14.74M -$17.83M $7.58M -$2.34M
Beginning Cash Balance $319.85M $305.11M $322.93M $315.35M $325.27M
Free Cash Flow -$9.67M -$33.40M -$20.82M -$93.89M -$18.72M
Gain/Loss from Continuing Operations – – – $10.39M $0.00

Discussion

No comments yet — be the first to weigh in on AXSM.

Sign in to join the discussion.

Scroll to Top